Soheyl Bahrami Selected Research

Traumatic Shock

10/2018	Secretome Conveys the Protective Effects of ASCs: Therapeutic Potential Following Hemorrhagic Shock?
8/2018	Organ-Specific Oxidative Events under Restrictive Versus Full Reperfusion Following Hemorrhagic Traumatic Shock in Rats.
1/2012	Alteration of complement hemolytic activity in different trauma and sepsis models.
11/2011	Transient increase of free iron in rat livers following hemorrhagic-traumatic shock and reperfusion is independent of heme oxygenase 1 upregulation.
6/2011	Xylazine-/diazepam-ketamine and isoflurane differentially affect hemodynamics and organ injury under hemorrhagic/traumatic shock and resuscitation in rats.
10/2010	Rons formation under restrictive reperfusion does not affect organ dysfunction early after hemorrhage and trauma.
9/2003	Increased plasma D-lactate is associated with the severity of hemorrhagic/traumatic shock in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Soheyl Bahrami Research Topics

Disease

20	Shock 01/2020 - 08/2002
18	Sepsis (Septicemia) 01/2019 - 06/2005
15	Hemorrhage 08/2017 - 05/2003
14	Wounds and Injuries (Trauma) 10/2021 - 08/2005
10	Inflammation (Inflammations) 01/2020 - 03/2006
10	Hemorrhagic Shock 01/2020 - 05/2003
7	Traumatic Shock 10/2018 - 09/2003
5	Ischemia 01/2020 - 11/2002
5	Endotoxemia 01/2018 - 11/2003
4	Infections 10/2018 - 06/2016
4	Mitochondrial Diseases (Mitochondrial Disease) 10/2017 - 10/2010
4	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2017 - 07/2004
3	Hypoxia (Hypoxemia) 01/2020 - 09/2009
3	Septic Shock (Toxic Shock Syndrome) 01/2019 - 06/2003
2	Reperfusion Injury 01/2020 - 08/2005
2	Multiple Sclerosis 01/2019 - 01/2018
2	Critical Illness (Critically Ill) 06/2014 - 06/2005
2	Liver Diseases (Liver Disease) 01/2013 - 09/2011
2	Necrosis 01/2007 - 08/2002
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Hypothermia 01/2020
1	Heart Arrest (Cardiac Arrest) 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Brain Hypoxia (Cerebral Hypoxia) 01/2019
1	Disseminated Intravascular Coagulation 03/2017
1	Peritonitis 06/2016
1	Thrombosis (Thrombus) 09/2012
1	Multiple Organ Failure (MODS) 09/2011

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2005
4	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2018 - 03/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2017 - 11/2002
3	Oxygen (Dioxygen)IBA 01/2020 - 10/2010
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 09/2003
3	AntioxidantsIBA 01/2018 - 03/2009
3	Nitric Oxide Synthase (NO Synthase)IBA 10/2017 - 11/2002
3	LipopolysaccharidesIBA 06/2016 - 11/2003
3	EndotoxinsIBA 09/2003 - 08/2002
2	Biological ProductsIBA 10/2021 - 01/2020
2	Epinephrine (Adrenaline)FDA LinkGeneric 11/2019 - 01/2018
2	Syndecan-1 (Syndecan 1)IBA 11/2019 - 01/2018
2	Conditioned Culture MediaIBA 01/2019 - 10/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2018
2	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 01/2018 - 12/2010
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 12/2010
2	EnzymesIBA 10/2017 - 01/2007
2	AntithrombinsIBA 03/2017 - 05/2012
2	Messenger RNA (mRNA)IBA 03/2014 - 11/2011
2	Plasminogen Activator Inhibitor 1IBA 01/2013 - 05/2012
2	Proteins (Proteins, Gene)FDA Link 05/2012 - 06/2005
2	Ringer's SolutionIBA 03/2006 - 09/2003
2	ProteomeIBA 02/2006 - 06/2005
2	Phosphopyruvate Hydratase (Enolase)IBA 08/2005 - 07/2004
1	SuspensionsIBA 10/2021
1	Biological FactorsIBA 10/2021
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 11/2019
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2019
1	Heparitin Sulfate (Heparan Sulfate)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 10/2018
1	Glutamic Acid (Glutamate)FDA Link 10/2017
1	fibrin fragment D (D-dimer)IBA 03/2017
1	Prothrombin (Factor II)IBA 03/2017
1	Dacarbazine (DIC)FDA LinkGeneric 03/2017
1	Thrombin FDA Link 03/2017
1	Factor X (Stuart Factor)IBA 03/2017
1	Factor Xa (Coagulation Factor Xa)IBA 03/2017
1	CatecholaminesIBA 03/2017
1	MitoTEMPOIBA 01/2017
1	C-Reactive ProteinIBA 06/2015
1	Cysteine-Rich Protein 61IBA 03/2014
1	Estrogens (Estrogen)FDA Link 02/2014
1	FibrinIBA 09/2012
1	Fibrinogen (Factor I)FDA Link 05/2012
1	Thromboplastin (Tissue Factor)IBA 05/2012
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2012
1	CytokinesIBA 01/2012
1	Complement System Proteins (Complement)IBA 01/2012
1	IronIBA 11/2011
1	Heme Oxygenase-1IBA 11/2011
1	Transferrin (beta 2 Transferrin)IBA 11/2011
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 11/2011
1	Hemin (Panhematin)FDA Link 11/2011
1	Diazepam (Valium)FDA LinkGeneric 06/2011

Therapy/Procedure

16	Resuscitation 01/2019 - 05/2003
8	Critical Care (Surgical Intensive Care) 01/2020 - 09/2011
7	Therapeutics 01/2019 - 09/2011
7	Ligation 01/2018 - 01/2004
7	Laparotomy 11/2011 - 05/2003
6	Punctures 01/2018 - 12/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 10/2021
2	Catheters 07/2004 - 05/2003
1	Induced Hypothermia 01/2020
1	Immunomodulation 01/2019
1	Artificial Skin 01/2018
1	Osteotomy 05/2012
1	Anesthesia 06/2011